Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  65 results for ""Lymphoma, Large B-Cell, Diffuse""

Your Filters

Language : chinese Subject : antineoplastic combined chemotherapy protocols
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

[Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].

  • Authors : Tang SH; Department of Hematology, Peking University Third Hospital, Beijing 100083, China.; Tian L

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/diagnosis ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/genetics

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2022 Sep 14; Vol. 43 (9), pp. 771-777.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[MYC and BCL-2 protein co-expression and prognosis of patients with diffuse large B-cell lymphoma: a propensity score matching analysis].

  • Authors : Zhan J; Department of Hematology, Chinese Academy of Medical Science & Peking Union Medical College, Peking Union Medical College Hospital, Beijing 100730, China.; Yang SJ

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Doxorubicin/Doxorubicin/Doxorubicin/therapeutic use

  • Source: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi [Zhonghua Xue Ye Xue Za Zhi] 2022 Jan 14; Vol. 43 (1), pp. 41-47.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 8212398 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Clinical Characteristics and Long-term Prognosis Analysis of Patients with Primary Bone Lymphoma].

  • Authors : Zhong KL; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.; Cao BP

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Adult CHOP protocol

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2022 Feb; Vol. 30 (1), pp. 126-130.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[The Effect of Bcl-6 Expression on the Prognosis of Newly Treated Double-Expressing Lymphoma Treated with R-CHOP Regimen].

  • Authors : Fan BJ; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, China.; Chen H

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Adolescent VAP-cyclo protocol

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Dec; Vol. 29 (6), pp. 1797-1801.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Cohort study of efficacy and safety of polatuzumab vedotin combined with immunochemotherapy in patients with relapse/refractory diffuse large B cell lymphoma].

  • Authors : Wu JQ; Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research/the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.; Liu YY

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Adult

  • Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2021 Jul 06; Vol. 101 (25), pp. 1985-1990.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Evaluation of GELTAMO-IPI for Patients with Diffuse Large B-cell Lymphoma].

  • Authors : Feng YX; Graduate School of Shanxi Medical University,Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030000, Shanxi Province, China.; Su LP

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Humans

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2021 Feb; Vol. 29 (1), pp. 98-103.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Programmed cell death-1 inhibitor combined with rituximab in refractory or relapsed diffuse large B-cell lymphoma: a preliminary efficacy and safety analysis].

  • Authors : Qin Y; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100021, China.; Zhao FY

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/antagonists & inhibitors

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2020 Dec 23; Vol. 42 (12), pp. 1034-1039.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

[Analysis of clinical characteristics, treatment and survival of elderly patients with large diffuse B-cell lymphoma].

  • Authors : Li CY; Department of Hematology, Third Hospital of Peking University, Beijing 100191, China.; Yang P

Subjects: Antineoplastic Combined Chemotherapy Protocols* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy; Aged, 80 and over

  • Source: Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2020 Nov 17; Vol. 100 (42), pp. 3296-3302.Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print)

Record details

Read More Add to Saved list
×
Academic Journal

[Clinical Characteristics and Prognosis of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma].

  • Authors : Zheng WS; Department of Hematology, Hainan Hospital of Chinese PLA General Hospital , Sanya 572000, Hainan Province, China.; Guan LX

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy; Aged

  • Source: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2020 Oct; Vol. 28 (5), pp. 1551-1557.Publisher: Zhongguo shi yan xue za zhi she Country of Publication: China NLM ID: 101084424 Publication Model: Print Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

[Clinical characteristics of 46 pediatric diffuse large B-cell lymphoma and treatment outcome].

  • Authors : Huang S; Department of Hematology and Oncology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.; Yang J

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*drug therapy ; Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/Lymphoma, Large B-Cell, Diffuse/*pathology

  • Source: Zhonghua er ke za zhi = Chinese journal of pediatrics [Zhonghua Er Ke Za Zhi] 2019 Oct 02; Vol. 57 (10), pp. 774-779.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 0417427 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  65 results for ""Lymphoma, Large B-Cell, Diffuse""